About
API Middleman
Areas of Focus
Categories
API Focused
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
1,338
By Phase
EARLY_PHASE1: 1PHASE1: 2PHASE3: 2
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04315064Collaborator
Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults with Recurrent Medulloblastoma
EARLY_PHASE1Completed
2 participants
Started: Apr 21, 2020 · Completed: May 2, 2023
NCT04262765Lead Sponsor
Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
PHASE1Completed
18 participants
Started: Feb 23, 2019 · Completed: Mar 26, 2019
NCT04245046Lead Sponsor
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
PHASE1Completed
18 participants
Started: Jan 18, 2019 · Completed: Feb 18, 2019
NCT00546507Lead Sponsor
Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I
PHASE3Completed
650 participants
Started: Oct 31, 2007 · Completed: Oct 31, 2008
NCT00546832Lead Sponsor
Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial II
PHASE3Completed
650 participants
Started: Oct 31, 2007 · Completed: Nov 30, 2008
Locations (1)
Headquarters
Ingelheim, Germany
Map
Loading map...